tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Xeris Biopharma Holdings Inc

XERS
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
8.200USD
+0.040+0.49%
์ข…๊ฐ€ย 09-18 16:00๏ผˆET๏ผ‰
1.42B์‹œ๊ฐ€์ด์•ก
106.45P/E TTM

Xeris Biopharma Holdings Inc

8.200
+0.040+0.49%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

XERS ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Xeris Biopharma Holdings Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
1.42B
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
106.45
์ฃผ๋‹น์ˆœ์ด์ต
0.08
์ˆ˜์ต
291.85M
์ˆœ์ด์ต
-54.84M
ROE
-617.16%
ROA
3.39%

Xeris Biopharma Holdings Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 6, 2026
EPS / ์˜ˆ์ƒ
-0.18/0.00
์ˆ˜์ต / ์˜ˆ์ƒ
92.10M/90.22M

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-1388.50%-0.18
121.66%0.01
294.75%0.07
103.59%0.00
88.05%-0.01
55.23%-0.06
64.65%-0.03
-19.64%-0.11
29.99%-0.10
-10.04%-0.14
-1.96%-0.10
---0.09
---0.14
---0.12
---0.10
---0.60
----
----
----
----
์ˆ˜์ต
28.74%92.10M
38.27%83.13M
42.78%85.81M
37.06%74.38M
48.84%71.54M
47.94%60.12M
35.39%60.10M
12.31%54.27M
26.46%48.06M
22.42%40.64M
33.93%44.39M
62.56%48.32M
50.19%38.01M
50.39%33.20M
54.67%33.14M
168.76%29.73M
184.15%25.31M
169.35%22.07M
198.79%21.43M
17.06%11.06M
์ˆœ์ด์ต
-1513.12%-31.10M
124.23%2.23M
316.72%11.08M
103.95%621.00K
87.15%-1.93M
51.42%-9.22M
61.81%-5.11M
-29.12%-15.74M
24.38%-15.01M
-12.75%-18.98M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
74.54%-12.93M
16.06%-21.83M
4.83%-26.18M
-83.12%-33.71M
-132.37%-50.79M
-62.56%-26.01M
์ˆœ์ด์ต๋ฅ 
-1153.00%-33.77%
117.52%2.69%
251.79%12.91%
102.88%0.83%
91.37%-2.70%
67.16%-15.34%
71.80%-8.51%
-14.96%-29.00%
40.20%-31.22%
7.90%-46.71%
22.68%-30.16%
---25.23%
---52.20%
---50.71%
---39.01%
---106.00%
----
----
----
----
์ด ์ด์ต๋ฅ 
4.89%83.47%
3.76%84.02%
5.47%84.08%
16.60%81.57%
1.82%79.58%
2.97%80.97%
3.75%79.72%
-9.64%69.96%
7.07%78.15%
3.73%78.64%
5.49%76.84%
--77.42%
--72.99%
--75.81%
--72.84%
--68.26%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-6.12%61.32%
-22.52%56.43%
-20.04%57.45%
-17.69%59.29%
-5.98%65.32%
6.75%72.84%
21.39%71.85%
23.98%72.03%
21.39%69.48%
16.86%68.23%
9.00%59.19%
--58.09%
--57.24%
--58.38%
--54.30%
--45.71%
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
28.74%92.10M
38.27%83.13M
42.78%85.81M
37.06%74.38M
48.84%71.54M
47.94%60.12M
35.39%60.10M
12.31%54.27M
26.46%48.06M
22.42%40.64M
33.93%44.39M
62.56%48.32M
50.19%38.01M
50.39%33.20M
54.67%33.14M
168.76%29.73M
184.15%25.31M
169.35%22.07M
198.79%21.43M
17.06%11.06M
์˜์—… ์ด์ต
15.42%5.17M
356.18%7.92M
898.99%16.77M
152.21%6.73M
154.75%4.48M
78.31%-3.09M
117.06%1.68M
-162.43%-12.89M
48.76%-8.19M
-7.29%-14.24M
35.13%-9.84M
73.70%-4.91M
15.53%-15.98M
30.39%-13.28M
67.07%-15.17M
15.31%-18.68M
13.57%-18.92M
-16.02%-19.07M
-138.18%-46.07M
-60.49%-22.06M
์ˆœ์ด์ต
-1513.12%-31.10M
124.23%2.23M
316.72%11.08M
103.95%621.00K
87.15%-1.93M
51.42%-9.22M
61.81%-5.11M
-29.12%-15.74M
24.38%-15.01M
-12.75%-18.98M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
74.54%-12.93M
16.06%-21.83M
4.83%-26.18M
-83.12%-33.71M
-132.37%-50.79M
-62.56%-26.01M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
48.05%274.76M
53.94%251.68M
43.33%240.31M
37.60%224.02M
8.95%185.58M
-5.65%163.49M
7.29%167.66M
3.00%162.80M
9.37%170.34M
4.69%173.28M
-16.35%156.26M
6.13%158.05M
-3.39%155.74M
-6.78%165.51M
31.01%186.82M
19.74%148.92M
11.49%161.21M
10.54%177.55M
-6.32%142.60M
-23.81%124.37M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
99.19%189.57M
24.74%118.59M
9.09%109.57M
27.67%116.20M
26.07%95.17M
30.09%95.07M
5.52%100.44M
4.57%91.01M
-5.26%75.49M
-10.24%73.08M
29.30%95.19M
26.96%87.04M
23.45%79.68M
22.46%81.42M
-6.86%73.62M
83.88%68.56M
82.00%64.55M
142.46%66.49M
180.21%79.04M
37.95%37.28M
์ด ์ž์‚ฐ
23.07%411.90M
24.27%392.01M
18.72%383.53M
15.29%370.19M
0.89%334.69M
-6.29%315.45M
0.14%323.06M
-2.04%321.10M
0.90%331.73M
4.75%336.62M
-6.36%322.60M
8.17%327.78M
3.19%328.78M
-4.82%321.36M
13.20%344.52M
130.85%303.02M
110.31%318.62M
101.40%337.62M
91.24%304.36M
-22.96%131.26M
๋ถ€์ฑ„ ์ด๊ณ„
19.11%421.64M
8.11%379.00M
4.87%369.84M
6.19%371.05M
0.85%353.99M
1.38%350.58M
7.07%352.68M
7.87%349.43M
11.39%351.02M
18.70%345.79M
10.04%329.38M
30.62%323.92M
28.80%315.14M
20.79%291.31M
43.13%299.33M
85.44%247.98M
85.91%244.67M
95.67%241.17M
66.78%209.13M
-14.31%133.72M
์ž๋ณธ ์ด๊ณ„
49.58%-9.73M
137.04%13.01M
146.22%13.69M
96.96%-861.00K
-0.09%-19.30M
-282.74%-35.13M
-336.67%-29.61M
-832.81%-28.32M
-241.38%-19.29M
-130.54%-9.18M
-115.01%-6.78M
-92.98%3.87M
-81.55%13.64M
-68.85%30.05M
-52.55%45.19M
2336.49%55.04M
271.80%73.94M
117.30%96.45M
182.07%95.23M
-117.17%-2.46M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
4440.11%8.26M
198.39%9.87M
914.84%20.04M
321.94%18.43M
101.76%182.00K
50.59%-10.03M
-73.56%1.98M
43.16%-8.30M
24.71%-10.35M
22.33%-20.30M
146.35%7.47M
17.71%-14.61M
33.31%-13.74M
46.00%-26.14M
44.31%-16.12M
21.48%-17.75M
-2.93%-20.61M
-102.07%-48.41M
-166.32%-28.95M
-33.12%-22.61M
์ˆœํˆฌ์ž
25.09%-209.00K
-2400.00%-325.00K
-103.32%-333.00K
-100.72%-71.00K
-106.06%-279.00K
99.93%-13.00K
-32.63%10.02M
-32.35%9.91M
-45.54%4.60M
55.32%-19.65M
62.17%14.87M
118.44%14.65M
-28.78%8.45M
-754.84%-43.98M
-74.95%9.17M
-63.74%6.71M
-28.32%11.87M
-74.46%6.72M
404.92%36.60M
130.50%18.50M
์ˆœ์žฌ๋ฌดํ™œ๋™
106.26%1.94M
-181.70%-8.84M
-166.83%-266.00K
16786.75%13.85M
42.94%942.00K
-108.91%-3.14M
132.25%398.00K
-15.28%-83.00K
18.53%659.00K
4178.10%35.19M
-102.51%-1.23M
61.50%-72.00K
79.35%556.00K
-101.10%-863.00K
39224.80%49.16M
-18800.00%-187.00K
-32.61%310.00K
193.29%78.19M
-96.24%125.00K
-99.99%1.00K

์ˆ˜์ต๎˜

์‚ฌ์—…๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ง€์—ญ๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Xeris Biopharma Holdings Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 291.85M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 203.07M์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 240.31M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 43.33์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Xeris Biopharma Holdings Inc์˜ ์ด์ž์‚ฐ์€ 383.53M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 18.72์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Xeris Biopharma Holdings Inc์˜ ์ด๋ถ€์ฑ„๋Š” 369.84M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 4.87์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Xeris Biopharma Holdings Inc์˜ ์ด์ž๋ณธ์€ 13.69M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 146.22์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Xeris Biopharma Holdings Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ 24.90M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 173.99์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Xeris Biopharma Holdings Inc์˜ ์ˆœํˆฌ์ž๋Š” -696.00K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -114.25์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Xeris Biopharma Holdings Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 11.39M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -68.51์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ 554.00K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 101.01์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ 0.19์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 100.70์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 81.70์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 6.76์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 57.45์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -20.04์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ 0.16์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 100.92์ž…๋‹ˆ๋‹ค.

Xeris Biopharma Holdings Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Xeris Biopharma Holdings Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ 24.90M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 173.99์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ